There are currently about 18,000 of these devices in the United States, and Abbott plans to scale up manufacturing to provide 50,000 tests per day. A test using a monoclonal antibody that specifically binds to the nucleocapsid protein (N protein) novel coronavirus is being developed in Taiwan, hoping it can provide results in 15-20 minutes, like a rapid flu test.
Kwa sasa kuna takriban mashine 18,000 nchini Marekani na Abbott inatarajia kuzidisha utengenezaji ili kutoa vipimo 50,000 kwa siku.Kipimo kinachotumia antibodi zinazofanana za protini ya nucleocapsid (protini aina ya N) ya virusi vipya vya korona vinaundwa nchini Taiwan, kukiwa na imani kuwa vitatoa matokeo baada ya dakika kati ya 15 hadi 20 kama tu vipimo vya homa ya mafua.